Report: Immune Checkpoint Proteins Are the Focus of Cancer Immunotherapy Development – AJMC.com Managed Markets Network
|
Report: Immune Checkpoint Proteins Are the Focus of Cancer Immunotherapy Development
AJMC.com Managed Markets Network Advancements in the cancer immunotherapy pipeline are leading to the production of immune checkpoint inhibitors, and a recent report from Global Business Intelligence (GBI) Research titled “Cancer Immunotherapies—First-in-Class Pipeline Dominated by … |
|
Report: Immune Checkpoint Proteins Are the Focus of Cancer Immunotherapy Development
AJMC.com Managed Markets Network Advancements in the cancer immunotherapy pipeline are leading to the production of immune checkpoint inhibitors, and a recent report from Global Business Intelligence (GBI) Research titled “Cancer Immunotherapies—First-in-Class Pipeline Dominated by … |
IBD News Today |
Mesenchymal Stem Cell Infusion a Possible Therapy for Crohn’s Fistulas, Review Study Suggests
IBD News Today Given this, Crohn’s disease patients need alternative therapy options. “Stem–cell therapies have recently been proposed as a method to address the challenges and prospective medical needs of Crohn’s disease patients in general and those with fistulas … |